Back to top
more

The Cooper Companies (COO)

(Delayed Data from NSDQ)

$92.69 USD

92.69
776,707

+0.08 (0.09%)

Updated Jul 30, 2024 04:00 PM ET

After-Market: $93.10 +0.41 (0.44%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 19% (203 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

The Cooper Companies Inc (COO), based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI). CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness. CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. This strategic business unit has pursued a strategy of consolidation by acquiring critical treatment niches in a fragmented market.

Here's Why You Should Retain Cooper Companies (COO) Stock

by Zacks Equity Research

Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

The Cooper (COO) Soars: Stock Adds 5.4% in Session

by Zacks Equity Research

The Cooper (COO) saw a big move last session, as its shares jumped nearly 5% on the day, amid huge volumes.

Cooper Companies (COO) Q3 Earnings & Revenues Top Estimates

by Zacks Equity Research

Cooper Companies' (COO) fiscal third-quarter earnings reflect dismal segmental performance. However, it exceeded expectation as it witnessed faster-than-anticipated recovery.

Cooper Cos. (COO) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Cooper Cos. (COO) delivered earnings and revenue surprises of 44.30% and 7.81%, respectively, for the quarter ended July 2020. Do the numbers hold clues to what lies ahead for the stock?

Cooper Companies (COO) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Cooper Companies' (COO) fiscal third-quarter performance is likely to reflect weak performance by CVI and CSI.

Earnings Preview: Cooper Cos. (COO) Q3 Earnings Expected to Decline

by Zacks Equity Research

Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PDCO vs. COO: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

PDCO vs. COO: Which Stock Is the Better Value Option?

Sriparna Ghosal headshot

3 Growth-Focused MedTech Stocks to Buy Amid Coronavirus Crisis

by Sriparna Ghosal

Once the pandemic-led crisis is over, these MedTech growth-focused stocks will flourish on a number of positive developments.

New Strong Sell Stocks for July 2nd

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

New Strong Sell Stocks for June 25th

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Trina Mukherjee headshot

Near-Term Outlook Bleak for Medical Dental Supplies Industry

by Trina Mukherjee

Digital influence coupled with AI & Robotics can drive the medical dental supplies industry amid the coronavirus-induced crisis.

Cooper Companies (COO) Misses on Q2 Earnings and Revenues

by Zacks Equity Research

Cooper Companies' (COO) fiscal second-quarter earnings reflect dismal segmental performance and decline in revenues.

Cooper Cos. (COO) Misses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Cooper Cos. (COO) delivered earnings and revenue surprises of -29.11% and -10.02%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?

Cooper Companies (COO) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

Cooper Companies' (COO) fiscal second-quarter performance is likely to reflect better-than-expected performance at CVI and CSI.

Analysts Estimate Cooper Cos. (COO) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Invest in Cooper Companies (COO) Stock

by Zacks Equity Research

Cooper Companies (COO) continues to gain traction from its robustly performing CVI and CSI businesses.

Masimo SafetyNet to Help Clinicians Fight Coronavirus Better

by Zacks Equity Research

Masimo (MASI) announces the full market release of Masimo SafetyNet, which is a remote patient management solution that will help in the fight against the COVID-19 pandemic.

AngioDyanamics (ANGO) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

AngioDynamics (ANGO) fiscal third-quarter results benefit from strong growth across all businesses and higher revenues.

Luminex (LMNX) Receives EUA for Coronavirus Detection Test

by Zacks Equity Research

Luminex (LMNX) receives EUA for its ARIES SARS-CoV-2 Assay, which will be used to rapidly detect the virus causing COVID-19.

Here's Why You Should Hold on to Stryker (SYK) Stock Now

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.

Here's Why You Should Hold on to Avanos Medical Stock Now

by Zacks Equity Research

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

BD Gets EUA for New Test to Combat the Coronavirus Crisis

by Zacks Equity Research

BD (BDX) partners with BioGX to introduce a new diagnostic test to help hospitals boost the capacity of quick, on-site testing of COVID-19.

Cooper Cos. (COO) Down 14% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Cooper Cos. (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MCK vs. COO: Which Stock Is the Better Value Option?

by Zacks Equity Research

MCK vs. COO: Which Stock Is the Better Value Option?

Here's Why You Should Add Integer Holdings to Your Portfolio

by Zacks Equity Research

Integer Holdings (ITGR) continues to gain traction from solid presence in the broader MedTech space and portfolio management.